| mRNA |
ABT-737 |
CTRPv2 |
pan-cancer |
AAC |
0.21 |
4e-09 |
| mRNA |
navitoclax:piperlongumine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
5e-08 |
| mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
5e-07 |
| mRNA |
BRD-K94991378 |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
5e-06 |
| mRNA |
ABT-263 |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
2e-05 |
| mRNA |
TAE684 |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
3e-05 |
| mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
3e-05 |
| mRNA |
navitoclax:birinapant (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
4e-05 |
| mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
6e-05 |
| mRNA |
piperlongumine |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0001 |